Qingyu Chen

Assistant Professor

National Institutes of Health
Country flagUnited States
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (7)

Background Existing large language model (LLM) evaluations rely on accuracy benchmarks that fail to capture whether models reason well while making diagnoses. Studies that do analyse reasoning focus on post hoc explanations accompanying model outputs rather than distinct, clinician-visible artifacts such as detailed reasoning traces. This creates a translational gap in domains such as psychiatry, where diagnosis relies on narrative interpretation, diagnostic reasoning, and clinical judgment under uncertainty. Methods We conducted a mixed-methods evaluation of four state-of-the-art LLMs using a clinician-curated dataset of 196 psychiatric case vignettes, including 135 published cases and 61 novel clinician-authored vignettes. Diagnostic accuracy was assessed using multiple metrics (top-1 accuracy, top-5 accuracy, recall@5, and mean reciprocal rank) based on ranked lists of five differential diagnoses per vignette. Clinical reasoning quality was evaluated on a randomly selected subset of 30 vignettes through clinician assessment of model-generated diagnostic reasoning traces alongside qualitative commentary from board-certified psychiatrists. We examined the association between clinician-rated reasoning quality and diagnostic correctness and included an illustrative comparison with psychiatry residents. Findings Clinician-rated diagnostic reasoning quality was strongly associated with diagnostic correctness in mixed-effects logistic regression analyses (β = 1·80; p < 0·001), whereas data extraction quality alone was not. Across the full vignette set, models demonstrated moderate to high diagnostic accuracy. The highest-performing model achieved a top-5 accuracy of 0·801 and also received the highest clinician-rated reasoning scores. In an illustrative comparison, model diagnostic accuracy fell within the range observed for psychiatry residents. Interpretation Diagnostic reasoning quality captures clinically meaningful variation in LLM performance beyond accuracy metrics. Psychiatry may represent a stringent testbed for evaluating reasoning in narrative-driven clinical domains. Evaluation frameworks for LLM-based clinical decision support should incorporate structured assessment of reasoning processes, not accuracy alone. Research in Context Evidence before this study We searched PubMed and Scopus for studies evaluating large language models for psychiatric diagnosis and/or differential diagnosis from text vignettes. Searches were run from database inception to February 6, 2026, using terms including (“large language model” OR LLM “artificial intelligence” OR “generative AI” OR AI OR ChatGPT OR GPT OR Claude OR Gemini OR DeepSeek OR Llama) AND (psychiatr* OR mental OR DSM OR “differential diagnosis” OR diagnos*) AND (vignette OR case OR “case report”). We included empirical studies that evaluated model diagnostic outputs using psychiatric cases/vignettes and excluded editorials/commentaries and studies that did not report case-level diagnostic performance. We did not formally assess risk of bias/quality; studies were heterogeneous in vignette sources, model access, and outcome definitions, precluding quantitative pooling. Prior studies have typically examined small vignette sets, focused on narrow diagnostic domains, evaluated single models, or relied primarily on outcome-based accuracy metrics. When diagnostic reasoning has been assessed, it has usually been inferred from post hoc explanations accompanying model outputs rather than evaluated as a distinct, clinician-visible artifact. Clinician-grounded evaluations of diagnostic reasoning across multiple contemporary models remain limited. Added value of this study This study provides a large-scale, clinician-grounded evaluation of diagnostic accuracy and diagnostic reasoning quality across four contemporary large language models using a diverse dataset of psychiatric case vignettes. Rather than relying solely on outcome-based explanations, we directly evaluated model-generated d

Year:

2026

Generative artificial intelligence (AI) is rapidly populating medical records with synthetic or partially AI-generated content, creating a feedback loop where future models are increasingly at risk of training on uncurated AI-generated data. However, the clinical consequences of this AI-generated data contamination remain unexplored. Here, we show that in the absence of mandatory human verification, this self-referential cycle drives a rapid erosion of pathological variability and diagnostic reliability of medical data at population scale. By analysing more than 800,000 synthetic data points across clinical text generation, vision–language reporting, and medical image synthesis, we find that models progressively converge toward generic phenotypes regardless of the model architectures. Specifically, rare but critical findings, including pneumothorax and effusions, vanish from the synthetic content generated by AI models, while demographic representations skew heavily toward middle-aged male phenotypes. Crucially, this degradation is masked by false diagnostic confidence. Models continue to issue reassuring reports while failing to detect life-threatening pathology, with false reassurance rates tripling to 40%. Blinded physician evaluation confirms that this decoupling of confidence and accuracy renders AI-generated documentation clinically useless after just two generations. We systematically evaluate three mitigation strategies that can be easily integrated into existing clinical workflows, finding that while synthetic volume scaling fails to prevent collapse, mixing real data with quality-aware filtering effectively preserves diversity. Ultimately, our results suggest that without policy-mandated human oversight, the deployment of generative AI threatens to degrade the very healthcare data ecosystems it relies upon.

Year:

2026

Summary Over 55% of author names in PubMed are ambiguous: the same name is shared by different individual researchers. This poses significant challenges on precise literature retrieval for author name queries, a common behavior in biomedical literature search. In response, we present a comprehensive dataset of disambiguated authors. Specifically, we complement the automatic PubMed Computed Authors algorithm with the latest ORCID data for improved accuracy. As a result, the enhanced algorithm achieves high performance in author name disambiguation, and subsequently our dataset contains more than 21 million disambiguated authors for over 35 million PubMed articles and is incrementally updated on a weekly basis. More importantly, we make the dataset publicly available for the community such that it can be utilized in a wide variety of potential applications beyond assisting PubMed’s author name queries. Finally, we propose a set of guidelines for best practices of authors pertaining to use of their names. Availability and implementation The PubMed Computed Authors dataset is publicly available for bulk download at: https://ftp.ncbi.nlm.nih.gov/pub/lu/ComputedAuthors/. Additionally, it is available for query through web API at: https://www.ncbi.nlm.nih.gov/research/bionlp/APIs/authors/.

Year:

2024

BACKGROUND Medical texts present significant domain-specific challenges, and manually curating these texts is a time-consuming and labor-intensive process. To address this, natural language processing (NLP) algorithms have been developed to automate text processing. In the biomedical field, various toolkits for text processing exist, which have greatly improved the efficiency of handling unstructured text. However, these existing toolkits tend to emphasize different perspectives, and none of them offer generation capabilities, leaving a significant gap in the current offerings. OBJECTIVE This study aims to describe the development and preliminary evaluation of Ascle. Ascle is tailored for biomedical researchers and clinical staff with an easy-to-use, all-in-one solution that requires minimal programming expertise. For the first time, Ascle provides 4 advanced and challenging generative functions: question-answering, text summarization, text simplification, and machine translation. In addition, Ascle integrates 12 essential NLP functions, along with query and search capabilities for clinical databases. METHODS We fine-tuned 32 domain-specific language models and evaluated them thoroughly on 27 established benchmarks. In addition, for the question-answering task, we developed a retrieval-augmented generation (RAG) framework for large language models that incorporated a medical knowledge graph with ranking techniques to enhance the reliability of generated answers. Additionally, we conducted a physician validation to assess the quality of generated content beyond automated metrics. RESULTS The fine-tuned models and RAG framework consistently enhanced text generation tasks. For example, the fine-tuned models improved the machine translation task by 20.27 in terms of BLEU score. In the question-answering task, the RAG framework raised the ROUGE-L score by 18% over the vanilla models. Physician validation of generated answers showed high scores for readability (4.95/5) and relevancy (4.43/5), with a lower score for accuracy (3.90/5) and completeness (3.31/5). CONCLUSIONS This study introduces the development and evaluation of Ascle, a user-friendly NLP toolkit designed for medical text generation. All code is publicly available through the Ascle GitHub repository. All fine-tuned language models can be accessed through Hugging Face.

Year:

2024

PubTator 3.0 (https://www.ncbi.nlm.nih.gov/research/pubtator3/) is a biomedical literature resource using state-of-the-art AI techniques to offer semantic and relation searches for key concepts like proteins, genetic variants, diseases and chemicals. It currently provides over one billion entity and relation annotations across approximately 36 million PubMed abstracts and 6 million full-text articles from the PMC open access subset, updated weekly. PubTator 3.0's online interface and API utilize these precomputed entity relations and synonyms to provide advanced search capabilities and enable large-scale analyses, streamlining many complex information needs. We showcase the retrieval quality of PubTator 3.0 using a series of entity pair queries, demonstrating that PubTator 3.0 retrieves a greater number of articles than either PubMed or Google Scholar, with higher precision in the top 20 results. We further show that integrating ChatGPT (GPT-4) with PubTator APIs dramatically improves the factuality and verifiability of its responses. In summary, PubTator 3.0 offers a comprehensive set of features and tools that allow researchers to navigate the ever-expanding wealth of biomedical literature, expediting research and unlocking valuable insights for scientific discovery.

Year:

2024

Motivation Large Language Models (LLMs) have the potential to revolutionize the field of Natural Language Processing, excelling not only in text generation and reasoning tasks but also in their ability for zero/few-shot learning, swiftly adapting to new tasks with minimal fine-tuning. LLMs have also demonstrated great promise in biomedical and healthcare applications. However, when it comes to Named Entity Recognition (NER), particularly within the biomedical domain, LLMs fall short of the effectiveness exhibited by fine-tuned domain-specific models. One key reason is that NER is typically conceptualized as a sequence labeling task, whereas LLMs are optimized for text generation and reasoning tasks. Results We developed an instruction-based learning paradigm that transforms biomedical NER from a sequence labeling task into a generation task. This paradigm is end-to-end and streamlines the training and evaluation process by automatically repurposing pre-existing biomedical NER datasets. We further developed BioNER-LLaMA using the proposed paradigm with LLaMA-7B as the foundational LLM. We conducted extensive testing on BioNER-LLaMA across three widely recognized biomedical NER datasets, consisting of entities related to diseases, chemicals, and genes. The results revealed that BioNER-LLaMA consistently achieved higher F1-scores ranging from 5% to 30% compared to the few-shot learning capabilities of GPT-4 on datasets with different biomedical entities. We show that a general-domain LLM can match the performance of rigorously fine-tuned PubMedBERT models and PMC-LLaMA, biomedical-specific language model. Our findings underscore the potential of our proposed paradigm in developing general-domain LLMs that can rival SOTA performances in multi-task, multi-domain scenarios in biomedical and health applications. Availability and implementation Datasets and other resources are available at https://github.com/BIDS-Xu-Lab/BioNER-LLaMA.

Year:

2024

Motivation While large language models (LLMs) have been successfully applied to various tasks, they still face challenges with hallucinations. Augmenting LLMs with domain-specific tools such as database utilities can facilitate easier and more precise access to specialized knowledge. In this article, we present GeneGPT, a novel method for teaching LLMs to use the Web APIs of the National Center for Biotechnology Information (NCBI) for answering genomics questions. Specifically, we prompt Codex to solve the GeneTuring tests with NCBI Web APIs by in-context learning and an augmented decoding algorithm that can detect and execute API calls. Results Experimental results show that GeneGPT achieves state-of-the-art performance on eight tasks in the GeneTuring benchmark with an average score of 0.83, largely surpassing retrieval-augmented LLMs such as the new Bing (0.44), biomedical LLMs such as BioMedLM (0.08) and BioGPT (0.04), as well as GPT-3 (0.16) and ChatGPT (0.12). Our further analyses suggest that: First, API demonstrations have good cross-task generalizability and are more useful than documentations for in-context learning; second, GeneGPT can generalize to longer chains of API calls and answer multi-hop questions in GeneHop, a novel dataset introduced in this work; finally, different types of errors are enriched in different tasks, providing valuable insights for future improvements. Availability and implementation The GeneGPT code and data are publicly available at https://github.com/ncbi/GeneGPT.

Year:

2024

Collaborators (18)

Walter Mathis

Yale University

UNITED STATES
View details

Matteo Malgaroli

Assistant Professor

NYU School of Medicine

UNITED STATES
View details

Ching-Yu Cheng

Professor

National University of Singapore (NUS)

SINGAPORE
View details

Tiarnan Keenan

National Institutes of Health

UNITED STATES
View details

Salih Selek

Professor

University of Texas System

UNITED STATES
View details

Chuan Hong

Duke University

UNITED STATES
View details

Irene Li

University of Tokyo

JAPAN
View details

Brian Zaboski

Assistant Professor

Yale University

UNITED STATES
View details

Emily Chew

NIH Distinguished Investigator

-

UNITED STATES
View details

Dean Ho

-

SINGAPORE
View details

Hua Xu

Yale University

UNITED STATES
View details

Ling Luo

Associate Professor

Dalian University of Technology

CHINA
View details

Jiyeong Kim

Assistant Professor

University of California, San Francisco

UNITED STATES
View details

Christopher Pittenger

Professor (secondary)

Yale University

UNITED STATES
View details

Dragomir Radev

Professor

Yale University

UNITED STATES
View details

Nan Liu

Associate Professor

National University of Singapore (NUS)

SINGAPORE
View details

Carolyn Rodriguez

Professor and Associate Dean

Stanford University

UNITED STATES
View details

Kun-Hsing Yu

Associate Professor

Harvard University

UNITED STATES
View details